GlassScriptPhysician profile
Robert L Simmons
NPI 1689633877
$4,381.61
in general payments reported to CMS, 2019-2025
15 companies · $469 in 2025
The $469 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $380 · 2021: $780 · 2022: $428 · 2023: $499 · 2024: $901 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622 · Travel and Lodging: $199 · Consulting Fee: $47.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.18 |
| Travel and Lodging | $199.00 |
| Consulting Fee | $47.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $841.23 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $711.26 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $688.90 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $638.26 | 2022-2025 | Infuse |
| Alcon Vision LLC | $573.70 | 2019-2025 | Precision7, Precision 1, Total30 |
| Shire North American Group INC | $140.36 | 2019 | |
| Allergan, INC. | $129.17 | 2019 | |
| Kala Pharmaceuticals, INC. | $122.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $113.87 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $113.37 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $99.23 | 2025 | Xdemvy |
| Horizon Therapeutics Plc | $90.61 | 2023 | Tepezza |
| Lkc Technologies, INC. | $72.65 | 2024 | |
| Abb Con-Cise Optical Group LLC | $29.90 | 2019 | |
| Abbvie INC. | $16.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.